Perhaps the answer to our food shortage lies in solving a simple, though still difficult, engineering problem: the ability to pick and harvest crops at speed and efficiency with minimum downtime.
The fed continues to slowly increase interest rates, but there will still be ample capital and enthusiasm in funding early stage innovation.
Should you be keeping track of macro events as a start up founder?
Despite and because of all the challenges lined up between bench-top and commercialization, it is critical to take a market-driven approach when picking a synthetic biology product.
In this day and age, it’s not about not paying more. It’s about finding a company that does better with more capital.
Our team at Creative Ventures prides itself on being market-driven deeptech investors. We’re looking for market-driven companies and not technologies in search of a problem.
Venture is as much a partnership between investors and founders as it is amongst the investment partners themselves. Thus, the best way to divide the venture pie is to simply create a larger pie where everyone ultimately has more than enough to eat.
Here are three must-have sections for when you’re compiling your empirical evidence:
We aren’t public health experts, but we have seen how COVID-19 has played out just like everyone else, especially the impact the Delta variant had. With information on Omicron still evolving (and quite rapidly), it’s can be difficult to avoid guessing how Omicron itself is different in order to actually make any decisions.
We’re wrapping up 2021 with anticipated ~50B record high investments in climate tech. Despite the capital rush, we stay disciplined to our market-driven approach, looking for deployable solutions with clear economic incentives.